Danish drugmaker Novo Nordisk said on Tuesday it had cut the price of its weight-loss drug, Wegovy, by up to 37% from its ...

As the market for weight management and anti-obesity grows rapidly in India, diagnostic players are hoping to cash in on the ...

Danish pharma major Novo Nordisk has slashed the price of Wegovy by up to 37%, to take on its key rival Eli Lilly. Here's how ...

In a video interview with Sohini Das, newly appointed Eli Lilly India President and General Manager Winselow Tucker outlines ...

Eli Lilly's Mounjaro became India's highest-selling drug in October with ₹100 crore sales. The anti-obesity treatment now leads a fast-growing market for GLP-1 and metabolic therapies.

Meghan Trainor is reclaiming her health and body after a gestational diabetes scare during pregnancy. She's now strength ...

Modern weight-loss medications like Ozempic and Mounjaro, originally for diabetes, are gaining attention for their ability to ...

Wegovy’s key competitor is Eli Lilly’s GLP-1 drug Mounjaro (tirzepatide), which became India’s top-selling medicine in ...

Wegovy’s price cut follows Mounjaro’s success in IndiaIndia key market for Novo Nordisk and Eli Lilly’s obesity drugsWegovy’s ...

Unsupervised GLP-1 use rises in India as structured, doctor-led platforms like Early.Fit push for safer, science-backed ...

Wegovy entered India in June and is playing catch-up to Eli Lilly's Mounjaro, whose sales have doubled within months of its launch in March.| News ...